639 results on '"Caro J Jaime"'
Search Results
2. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation
3. The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada
4. Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas
5. Hospitalization for pertussis: profiles and case costs by age
6. Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K
7. Cost of managing complications resulting from type 2 diabetes mellitus in Canada
8. A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes
9. The Impact of Restrictive Transfusion Practices on Hemodynamically Stable Critically Ill Children Without Heart Disease: A Secondary Analysis of the Age of Blood in Children in the PICU Trial*
10. Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
11. Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France
12. Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models
13. Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France
14. 1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach
15. Novel Approaches to Value Assessment Beyond the Cost-Effectiveness Framework
16. Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812
17. DICE Simulation
18. The Use of MCDA in HTA: Great Potential, but More Effort Needed
19. Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
20. Trusting the Results of Model-Based Economic Analyses: Is there a Pragmatic Validation Solution?
21. Traditional and Innovative Study Designs in Comparative Effectiveness Research
22. Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study
23. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
24. Improving Transparency in Decision Models: Current Issues and Potential Solutions
25. Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas
26. Validation of a DICE Simulation Against a Discrete Event Simulation Implemented Entirely in Code
27. Amplifying Each Patient’s Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients
28. Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics
29. Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry
30. Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
31. Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
32. Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
33. Adjusting for Patient Crossover in Clinical Trials Using External Data: A Case Study of Lenalidomide for Advanced Multiple Myeloma
34. Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial
35. The Emerging Infectious Challenge of Clostridium difficile –Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences
36. The nature of the selection of candidates for cardiac transplant
37. Decision-Analytic Models: Current Methodological Challenges
38. Traditional and Innovative Study Designs in Comparative Effectiveness Research
39. Evaluating Montréal’s harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis
40. Risk factors in adolescents as predictors of arterial hypertension in adults: Protocol for a systematic review
41. Response to Letter to the Editor Regarding Discretely Integrated Condition Event Simulation for Pharmacoeconomics
42. Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences
43. Economic Evaluation of Atorvastatin for Prevention of Recurrent Stroke Based on the SPARCL Trial
44. Cost-Effectiveness of Clopidogrel plus Aspirin versus Aspirin Alone for Secondary Prevention of Cardiovascular Events: Results from the CHARISMA Trial
45. Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States
46. Economic Benefit Analysis of Primary Prevention with Pravastatin
47. Additional file 1 of The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada
48. A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
49. Risk of discontinuation of risperidone after exposure to potentially interacting drugs: A nested case-control study in patients with schizophrenia
50. Modelización del beneficio clínico y del impacto económico del implante de marcapasos con modo de estimulación ventricular minimizada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.